Federal contract award
HT942524F0269
NOVEL NANOTHERAPEUTICS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AJ11 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH |
| Parent award / vehicle | HT942523D0011 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.9M |
| Current contract value | $1.9M |
| Potential contract value / ceiling | $1.9M |
| Start date | Sep 20, 2024 |
| Current end date | Dec 31, 2025 |
| Potential end date | Dec 31, 2025 |
| Latest award activity | Jul 2, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 2, 2025 | P00003 | $424.2K | NOVEL NANOTHERAPEUTICS |
| May 13, 2025 | P00002 | $0 | NOVEL NANOTHERAPEUTICS |
| Feb 11, 2025 | P00001 | $358.3K | NOVEL NANOTHERAPEUTICS |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.